Your browser doesn't support javascript.
loading
Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use.
Jackson, David J; Burhan, Hassan; Menzies-Gow, Andrew; Pfeffer, Paul; Nanzer, Alexandra; Garcia Gil, Esther; Morris, Tamsin; Tran, Trung N; Hirsch, Ian; Dube, Sabada.
Afiliação
  • Jackson DJ; Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, United Kingdom; Asthma UK Centre, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom. Electronic address: David.Jackson@gstt.nhs.uk.
  • Burhan H; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
  • Menzies-Gow A; Royal Brompton Hospital, London, United Kingdom.
  • Pfeffer P; Barts Health NHS Trust, London, United Kingdom.
  • Nanzer A; Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, United Kingdom.
  • Garcia Gil E; Global Medical Respiratory, BioPharmaceuticals Medical, AstraZeneca, Barcelona, Spain.
  • Morris T; UK Medical and Scientific Affairs, AstraZeneca, Luton, United Kingdom.
  • Tran TN; AstraZeneca, Gaithersburg, Md.
  • Hirsch I; BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Dube S; UK Medical and Scientific Affairs, AstraZeneca, Luton, United Kingdom.
J Allergy Clin Immunol Pract ; 10(6): 1534-1544.e4, 2022 06.
Article em En | MEDLINE | ID: mdl-35202871
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article